The leadership change comes as the retail pharmacy industry faces thin profit margins, store closures, and layoffs.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
After nearly 3,000 years, the business of the Olympics is ripe for disruption. Could performance enhancing drugs shake up the games?
The Department of Health announced this week that Medicare is cutting prices for dozens of prescription drugs that have outpaced inflation.
US equity ETFS saw nearly $150 billion in inflows last month. Those tied to Europe, Japan, and emerging markets weren’t so lucky.
By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals’ dominance in the GLP-1 space.
If similar cases are a guide, the US has given equal weight to both known and hypothetical threats to national security.